icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Treatment with Growth Hormone-Releasing Hormone Analog Reduces VEGFA, TGFβ1, and CSF1: Mechanisms of Tesamorelin Effect in Nonalcoholic Fatty Liver Disease
 
 
  AASLD 2020 Nov 11-16 virtual
 
Lindsay T. Fourman, M.D.

1117201

1117202

1117203

1117204

1117205

1117206

1117207